Tumour DNA circulating in the bloodstream of patients with aggressive lymphoma can help to monitor how well treatments are working. #cancer @iCAN_Finland @HelsinkiUniMed https://t.co/C6o11Y2m2X
— University of Helsinki (@helsinkiuni) March 27, 2022 08:15